D-erythro-Sphingosine 1-phosphate
CAS: 26993-30-6
Ref. 3D-FD57792
1mg | 364,00 € | ||
2mg | 517,00 € | ||
5mg | 801,00 € | ||
10mg | 1.044,00 € | ||
25mg | 2.087,00 € |
Información del producto
- Sphingosine- 1- phosphate
- (4E)-2-Amino-3-hydroxy-4-octadecen-1-yl dihydrogen phosphate
- (4E)-2-Amino-3-hydroxy-4-octadecen-1-yldihydrogen-phosphat
- (4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate
- 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-
- 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (E)-<span class="text-smallcaps">D</span>-erythro-
- 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), [R-[R*,S*-(E)]]-
- <span class="text-smallcaps">D</span>-erythro-Sphingosine-1-phosphate
- C<sub>18</sub>-Sphingosine 1-phosphate
- Dihydrogène phosphate de (4E)-2-amino-3-hydroxy-4-octadécèn-1-yle
- Ver más sinónimos
- Proteins, S1P
- S1P protein
- Sphingosine 1-phosphate
- Sphingosine 1-phosphic acid
- D-erythro-Sphingosine-1-phosphate
- D-erythro-Sphingosine 1-phosphate
- 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (E)-D-erythro-
D-Erythro-sphingosine 1-phosphate (D-ESP) is a phospholipid that belongs to the sphingosine family. It binds to cell surface receptors and has a variety of physiological effects such as increasing intracellular levels of Ca2+ and inhibiting platelet aggregation. D-ESP has been shown to inhibit the enzyme adenylyl cyclase, which converts ATP into cAMP, in the presence of chemical inhibitors. This inhibition can be reversed by the addition of cAMP or by adding adenylyl cyclase activators such as forskolin. D-ESP also inhibits phosphorylation of c-Jun and affects gene transcription, protein synthesis and cellular physiology.
Propiedades químicas
Consulta técnica sobre: 3D-FD57792 D-erythro-Sphingosine 1-phosphate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.